Alembic Pharma gets USFDA nod for Haloperidol tablets; addresses $27 million market
Shares of Alembic Pharmaceuticals Ltd. rose from the day’s lows on Friday, June 5, after the drugmaker received final approval from the US Food and Drug Administration (USFDA) for its generic version of Haloperidol Tablets. In an exchange filing, the company said it has received USFDA approval for Haloperidol Tablets USP in strengths of 1…
